Compare IPSC & PLBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IPSC | PLBC |
|---|---|---|
| Founded | 2019 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 441.9M | 363.9M |
| IPO Year | 2021 | 2002 |
| Metric | IPSC | PLBC |
|---|---|---|
| Price | $2.22 | $55.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $4.25 | ★ $57.67 |
| AVG Volume (30 Days) | ★ 902.3K | 47.7K |
| Earning Date | 05-11-2026 | 04-15-2026 |
| Dividend Yield | N/A | ★ 2.60% |
| EPS Growth | ★ 91.30 | N/A |
| EPS | N/A | ★ 1.38 |
| Revenue | ★ $109,164,000.00 | N/A |
| Revenue This Year | N/A | $25.59 |
| Revenue Next Year | N/A | $5.15 |
| P/E Ratio | ★ N/A | $39.64 |
| Revenue Growth | ★ 1556.76 | N/A |
| 52 Week Low | $0.44 | $39.70 |
| 52 Week High | $2.97 | $55.94 |
| Indicator | IPSC | PLBC |
|---|---|---|
| Relative Strength Index (RSI) | 48.41 | 68.69 |
| Support Level | $2.13 | $50.35 |
| Resistance Level | $2.45 | N/A |
| Average True Range (ATR) | 0.16 | 1.24 |
| MACD | -0.01 | 0.23 |
| Stochastic Oscillator | 43.12 | 78.64 |
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.
Plumas Bancorp provides banking products and services in Northeastern California and Northwestern Nevada, offering a range of deposit products for commercial and retail customers, including checking, savings, money market accounts, time deposits, retirement accounts, and sweep accounts for businesses and public entities, along with digital banking services such as mobile and internet banking, remote deposit, and electronic funds transfers, as well as other customary banking services. Its loan portfolio comprises commercial real estate, commercial and industrial, consumer, agricultural, residential real estate, and construction and land development loans, and the company generates its revenue from loans and investment securities, with additional income from service fees.